Diet X Genotype Study
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Obesity Weight Loss, Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 4/21/2016 |
| Start Date: | March 2013 |
| End Date: | June 2016 |
Do Genotype Patterns Predict Weight Loss Success for Low Carb vs. Low Fat Diets?
Genomics research is advancing rapidly, and links between genes and obesity continue to be
discovered and better defined. A growing number of single nucleotide polymorphisms (SNPs) in
multiple genes have been shown to alter an individual's response to dietary macronutrient
composition. Based on prior genetic studies evaluating the body's physiological responses to
dietary carbohydrates or fats, the investigators identified multi-locus genotype patterns
with SNPs from three genes (FABP2, PPARG, and ADRB2): a low carbohydrate-responsive genotype
(LCG) and a low fat-responsive genotype (LFG). In a preliminary, retrospective study (using
the A TO Z weight loss study data), the investigators observed a 3-fold difference in
12-month weight loss for initially overweight women who were determined to have been
appropriately matched vs. mismatched to a low carbohydrate (Low Carb) or low fat (Low Fat)
diet based on their multi-locus genotype pattern. The primary objective of this study is to
confirm and expand on the preliminary results and determine if weight loss success can be
increased if the dietary approach (Low Carb vs. Low Fat) is appropriately matched to an
individual' s genetic predisposition (Low Carb Genotype vs. Low Fat Genotype) toward those
diets.
discovered and better defined. A growing number of single nucleotide polymorphisms (SNPs) in
multiple genes have been shown to alter an individual's response to dietary macronutrient
composition. Based on prior genetic studies evaluating the body's physiological responses to
dietary carbohydrates or fats, the investigators identified multi-locus genotype patterns
with SNPs from three genes (FABP2, PPARG, and ADRB2): a low carbohydrate-responsive genotype
(LCG) and a low fat-responsive genotype (LFG). In a preliminary, retrospective study (using
the A TO Z weight loss study data), the investigators observed a 3-fold difference in
12-month weight loss for initially overweight women who were determined to have been
appropriately matched vs. mismatched to a low carbohydrate (Low Carb) or low fat (Low Fat)
diet based on their multi-locus genotype pattern. The primary objective of this study is to
confirm and expand on the preliminary results and determine if weight loss success can be
increased if the dietary approach (Low Carb vs. Low Fat) is appropriately matched to an
individual' s genetic predisposition (Low Carb Genotype vs. Low Fat Genotype) toward those
diets.
If the intriguing preliminary retrospective results are confirmed in this full scale study,
the results will demonstrate that inexpensive DNA testing could help dieters predict whether
they will have greater weight loss success on a Low Carb or a Low Fat diet. Commensurate
with increasing scientific interest in personalized medicine approaches to intervention
development, this would provide an example of the potentially substantial health impacts
that could be obtained through understanding specific gene-environment interactions that
have been anticipated from the unraveling of the human genome.
Mobile App Sub-Study—For the purpose of augmenting adherence to high vegetable consumption
in both diet groups, we will develop a theory-based mobile app to increase vegetable
consumption through goal-setting, self-monitoring, and social comparison. Participants from
both diet groups with iPhones will be re-randomized to receive the app at either months 4-5
or months 7-8. The first phase during months 4-7 will be used to compare the effect of a
mobile app (intervention) vs. no mobile app (waiting-list control). The a priori hypothesis
is that vegetable consumption will increase among those who receive the app in both diet
arms. The investigator and outcomes assessor will be blinded to group assignment.
Intention-to-treat analysis will be used.
the results will demonstrate that inexpensive DNA testing could help dieters predict whether
they will have greater weight loss success on a Low Carb or a Low Fat diet. Commensurate
with increasing scientific interest in personalized medicine approaches to intervention
development, this would provide an example of the potentially substantial health impacts
that could be obtained through understanding specific gene-environment interactions that
have been anticipated from the unraveling of the human genome.
Mobile App Sub-Study—For the purpose of augmenting adherence to high vegetable consumption
in both diet groups, we will develop a theory-based mobile app to increase vegetable
consumption through goal-setting, self-monitoring, and social comparison. Participants from
both diet groups with iPhones will be re-randomized to receive the app at either months 4-5
or months 7-8. The first phase during months 4-7 will be used to compare the effect of a
mobile app (intervention) vs. no mobile app (waiting-list control). The a priori hypothesis
is that vegetable consumption will increase among those who receive the app in both diet
arms. The investigator and outcomes assessor will be blinded to group assignment.
Intention-to-treat analysis will be used.
Inclusion Criteria:
- Age: > 18 years of age
- Women: Pre-menopausal (self-report) and <50 years of age
- Men: <50 years of age
- BMI (body mass index): 27-40 kg/m2 (need to lose >10% body weight to achieve healthy
BMI)
- Body weight stable for the last two months, and not actively on a weight loss plan
- No plans to move from the area over the next two years
- Available and able to participate in the evaluations and intervention for the study
period
- Willing to accept random assignment
- To enhance study generalizability, people on medications not noted below as specific
exclusions can
- participate if they have been stable on such medications for at least three months
- Ability and willingness to give written informed
- No known active psychiatric illness
Exclusion Criteria:
Subjects with the following conditions will be excluded (determined by self-report):
- Pregnant, lactating, within 6 months post-partum, or planning to become pregnant in
the next 2 years
- Diabetes (type 1 and 2) or history of gestational diabetes or on hypoglycemic
medications for any other indication
- Prevalent diseases: Malabsorption, renal or liver disease, active neoplasms, recent
myocardial infarction (<6 months)(patient self-report and, if available, review of
labs from primary care provider)
- Smokers (because of effect on weight and lipids)
- History of serious arrhythmias, or cerebrovascular disease
- Uncontrolled hyper- or hypothyroidism (TSH not within normal limits)
- Medications: Lipid lowering, antihypertensive medications, and those known to affect
weight/energy expenditure
- Excessive alcohol intake (self-reported, >3 drinks/day)
- Musculoskeletal disorders precluding regular physical activity
- Unable to follow either of the two study diets for reasons of food allergies or other
(e.g., vegan)
- Currently under psychiatric care, or taking psychiatric medications
- Inability to communicate effectively with study personnel
We found this trial at
1
site
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
